{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T22:19:16Z","timestamp":1791152356291,"version":"4.1.0"},"reference-count":79,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":562,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HD064993"],"award-info":[{"award-number":["HD064993"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS058382"],"award-info":[{"award-number":["NS058382"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG005119"],"award-info":[{"award-number":["AG005119"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL086341"],"award-info":[{"award-number":["HL086341"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012513","name":"Coins for Alzheimer's Research Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012513","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["IIRG-10-172905"],"award-info":[{"award-number":["IIRG-10-172905"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.ajpath.2011.09.034","type":"journal-article","created":{"date-parts":[[2011,11,8]],"date-time":"2011-11-08T11:37:07Z","timestamp":1320752227000},"page":"337-350","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["BACE2 Expression Increases in Human Neurodegenerative Disease"],"prefix":"10.1016","volume":"180","author":[{"given":"Christopher J.","family":"Holler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin L.","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley L.","family":"Laux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina L.","family":"Beckett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana M.","family":"Niedowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel R.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinxing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher R.","family":"Simmons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy L.S.","family":"Dowling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Spinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moshe","family":"Khurgel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Estus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Head","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis B.","family":"Hersh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Paul","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2011.09.034_bib1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1126\/science.1058783","article-title":"A transcriptively active complex of APP with Fe65 and histone acetyltransferase Tip60","volume":"293","author":"Cao","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2011.09.034_bib2","doi-asserted-by":"crossref","first-page":"5637","DOI":"10.1074\/jbc.M109119200","article-title":"Apical sorting of \u03b2-secretase limits amyloid \u03b2-peptide production","volume":"277","author":"Capell","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2011.09.034_bib3","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1126\/science.286.5440.735","article-title":"\u03b2-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE","volume":"286","author":"Vassar","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2011.09.034_bib4","doi-asserted-by":"crossref","first-page":"30849","DOI":"10.1074\/jbc.M003202200","article-title":"Maturation and pro-peptide cleavage of \u03b2-secretase","volume":"275","author":"Capell","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2011.09.034_bib5","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1126\/science.1132341","article-title":"Control of peripheral nerve myelination by the \u03b2-secretase BACE1","volume":"314","author":"Willem","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2011.09.034_bib6","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nm.1940","article-title":"Amyloid precursor protein secretases as therapeutic targets for traumatic brain injury","volume":"15","author":"Loane","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.ajpath.2011.09.034_bib7","doi-asserted-by":"crossref","first-page":"17362","DOI":"10.1073\/pnas.1012568107","article-title":"Soluble amyloid precursor protein (APP) regulates transthyretin and Klotho gene expression without rescuing the essential function of APP","volume":"107","author":"Li","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2011.09.034_bib8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0169-328X(03)00182-7","article-title":"Quantification and distribution of \u03b2-secretase alternative splice variants in the rat and human brain","volume":"115","author":"Zohar","year":"2003","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.ajpath.2011.09.034_bib9","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1006\/mcne.2000.0884","article-title":"ASP1 (BACE2) cleaves the amyloid precursor protein at the \u03b2-secretase site","volume":"16","author":"Hussain","year":"2000","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.ajpath.2011.09.034_bib10","doi-asserted-by":"crossref","first-page":"31512","DOI":"10.1074\/jbc.M300169200","article-title":"Antagonistic effects of \u03b2-site amyloid precursor protein-cleaving enzymes 1 and 2 on \u03b2-amyloid peptide production in cells","volume":"278","author":"Basi","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2011.09.034_bib11","doi-asserted-by":"crossref","first-page":"20647","DOI":"10.1074\/jbc.M002688200","article-title":"Expression analysis of BACE2 in brain and peripheral tissues","volume":"275","author":"Bennett","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2011.09.034_bib12","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1385\/JMN:29:1:81","article-title":"Characterization of the human \u03b2-secretase 2 (BACE2) 5\u2032-flanking region: identification of a 268-bp region as the basal BACE2 promoter","volume":"29","author":"Maloney","year":"2006","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.ajpath.2011.09.034_bib13","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0014-5793(00)01192-3","article-title":"The gene encoding DRAP (BACE2), a glycosylated transmembrane protein of the aspartic protease family, maps to the down critical region","volume":"468","author":"Acquati","year":"2000","journal-title":"FEBS Lett"},{"key":"10.1016\/j.ajpath.2011.09.034_bib14","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0304-3940(02)00287-2","article-title":"Elevated expression of \u03b2-site amyloid precursor protein cleaving enzyme 2 in brains of patients with Down syndrome","volume":"326","author":"Motonaga","year":"2002","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.ajpath.2011.09.034_bib15","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/85059","article-title":"Mice deficient in BACE1, the Alzheimer's \u03b2-secretase, have normal phenotype and abolished \u03b2-amyloid generation","volume":"4","author":"Luo","year":"2001","journal-title":"Nature neuroscience"},{"key":"10.1016\/j.ajpath.2011.09.034_bib16","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.nbd.2006.12.008","article-title":"BACE1 gene deletion prevents neuron loss and memory deficits in 5XFAD APP\/PS1 transgenic mice","volume":"26","author":"Ohno","year":"2007","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.ajpath.2011.09.034_bib17","doi-asserted-by":"crossref","first-page":"8819","DOI":"10.1523\/JNEUROSCI.1334-10.2010","article-title":"BACE1 deficiency causes altered neuronal activity and neurodegeneration","volume":"30","author":"Hu","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.ajpath.2011.09.034_bib18","doi-asserted-by":"crossref","first-page":"5585","DOI":"10.1073\/pnas.0710373105","article-title":"Alteration of BACE1-dependent NRG1\/ErbB4 signaling and schizophrenia-like phenotypes in BACE1-null mice","volume":"105","author":"Savonenko","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2011.09.034_bib19","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/85064","article-title":"BACE1 is the major \u03b2-secretase for generation of A\u03b2 peptides by neurons","volume":"4","author":"Cai","year":"2001","journal-title":"Nature neuroscience"},{"key":"10.1016\/j.ajpath.2011.09.034_bib20","doi-asserted-by":"crossref","first-page":"30797","DOI":"10.1074\/jbc.M505249200","article-title":"Phenotypic and biochemical analyses of BACE1- and BACE2-deficient mice","volume":"280","author":"Dominguez","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2011.09.034_bib21","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1073\/pnas.0205689101","article-title":"Amyloid \u03b2 peptide load is correlated with increased \u03b2-secretase activity in sporadic Alzheimer's disease patients","volume":"101","author":"Li","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2011.09.034_bib22","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/j.1471-4159.2009.06528.x","article-title":"BACE1 and BACE2 enzymatic activities in Alzheimer's disease","volume":"112","author":"Ahmed","year":"2010","journal-title":"J Neurochem"},{"key":"10.1016\/j.ajpath.2011.09.034_bib23","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1001\/archneur.59.9.1381","article-title":"\u03b2-secretase protein and activity are increased in the neocortex in Alzheimer disease","volume":"59","author":"Fukumoto","year":"2002","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ajpath.2011.09.034_bib24","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/ana.10208","article-title":"Increased expression of the amyloid precursor \u03b2-secretase in Alzheimer's disease","volume":"51","author":"Holsinger","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ajpath.2011.09.034_bib25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/nm0103-3","article-title":"Elevated \u03b2-secretase expression and enzymatic activity detected in sporadic Alzheimer disease","volume":"9","author":"Yang","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.ajpath.2011.09.034_bib26","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1212\/01.wnl.0000229925.52203.4c","article-title":"CSF BACE1 activity is increased in CJD and Alzheimer disease versus [corrected] other dementias","volume":"67","author":"Holsinger","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.ajpath.2011.09.034_bib27","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1001\/archneur.65.8.1102","article-title":"Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease","volume":"65","author":"Zetterberg","year":"2008","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ajpath.2011.09.034_bib28","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1159\/000110739","article-title":"Elevated platelet \u03b2-secretase activity in mild cognitive impairment","volume":"24","author":"Liu","year":"2007","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.ajpath.2011.09.034_bib29","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.neurobiolaging.2009.04.002","article-title":"Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease","volume":"30","author":"Price","year":"2009","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.ajpath.2011.09.034_bib30","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/archneur.56.3.303","article-title":"Mild cognitive impairment: clinical characterization and outcome","volume":"56","author":"Petersen","year":"1999","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ajpath.2011.09.034_bib31","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00401-007-0237-2","article-title":"Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration","volume":"114","author":"Cairns","year":"2007","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.ajpath.2011.09.034_bib32","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1212\/WNL.55.3.370","article-title":"\u201cPreclinical\u201d AD revisited: neuropathology of cognitively normal older adults","volume":"55","author":"Schmitt","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.ajpath.2011.09.034_bib33","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1750-3639.2008.00244.x","article-title":"Modeling the association between 43 different clinical and pathological variables and the severity of cognitive impairment in a large autopsy cohort of elderly persons","volume":"20","author":"Nelson","year":"2010","journal-title":"Brain Pathol"},{"key":"10.1016\/j.ajpath.2011.09.034_bib34","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.nbd.2010.05.018","article-title":"Effects of nonsteroidal anti-inflammatory drugs on amyloid-\u03b2 pathology in mouse skeletal muscle","volume":"39","author":"Beckett","year":"2010","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.ajpath.2011.09.034_bib35","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0002-9440(10)63159-8","article-title":"\u03b2-Secretase activity increases with aging in human, monkey, and mouse brain","volume":"164","author":"Fukumoto","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2011.09.034_bib36","doi-asserted-by":"crossref","first-page":"15345","DOI":"10.1021\/bi050650l","article-title":"Susceptibility of amyloid \u03b2 peptide degrading enzymes to oxidative damage: a potential Alzheimer's disease spiral","volume":"44","author":"Shinall","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.ajpath.2011.09.034_bib37","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1021\/jm00030a009","article-title":"N-Phosphonomethyl dipeptides and their phosphonate prodrugs, a new generation of neutral endopeptidase (NEP, EC 3.4.24.11) inhibitors","volume":"37","author":"De Lombaert","year":"1994","journal-title":"J Med Chem"},{"key":"10.1016\/j.ajpath.2011.09.034_bib38","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.neuron.2005.06.030","article-title":"A\u03b242 is essential for parenchymal and vascular amyloid deposition in mice","volume":"47","author":"McGowan","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.ajpath.2011.09.034_bib39","doi-asserted-by":"crossref","first-page":"637","DOI":"10.3233\/JAD-2010-1397","article-title":"Amyloid-\u03b2 peptide and oligomers in the brain and cerebrospinal fluid of aged canines","volume":"20","author":"Head","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.ajpath.2011.09.034_bib40","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/humu.21244","article-title":"Role of SFRS13A in low-density lipoprotein receptor splicing","volume":"31","author":"Ling","year":"2010","journal-title":"Hum Mutat"},{"key":"10.1016\/j.ajpath.2011.09.034_bib41","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1006\/nbdi.1996.0003","article-title":"Sequence of deposition of heterogeneous amyloid \u03b2-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation","volume":"3","author":"Lemere","year":"1996","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.ajpath.2011.09.034_bib42","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1523\/JNEUROSCI.4396-06.2007","article-title":"\u03b2-Site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: implications for Alzheimer's disease pathogenesis","volume":"27","author":"Zhao","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.ajpath.2011.09.034_bib43","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.neuron.2008.10.047","article-title":"Phosphorylation of the translation initiation factor eIF2\u03b1 increases BACE1 levels and promotes amyloidogenesis","volume":"60","author":"O'Connor","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.ajpath.2011.09.034_bib44","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1126\/science.1059946","article-title":"Metabolic regulation of brain A\u03b2 by neprilysin","volume":"292","author":"Iwata","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2011.09.034_bib45","doi-asserted-by":"crossref","first-page":"6550","DOI":"10.1016\/j.febslet.2006.10.076","article-title":"Altered \u03b2-secretase enzyme kinetics and levels of both BACE1 and BACE2 in the Alzheimer's disease brain","volume":"580","author":"Stockley","year":"2006","journal-title":"FEBS Lett"},{"key":"10.1016\/j.ajpath.2011.09.034_bib46","doi-asserted-by":"crossref","first-page":"53205","DOI":"10.1074\/jbc.M410378200","article-title":"Dimerization of \u03b2-site \u03b2-amyloid precursor protein-cleaving enzyme","volume":"279","author":"Westmeyer","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2011.09.034_bib47","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00726-007-0618-9","article-title":"Protein expression of BACE1: BACE2 and APP in Down syndrome brains","volume":"35","author":"Cheon","year":"2008","journal-title":"Amino Acids"},{"key":"10.1016\/j.ajpath.2011.09.034_bib48","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0014-4886(03)00049-9","article-title":"BACE-2 is overexpressed in Down's syndrome","volume":"182","author":"Barbiero","year":"2003","journal-title":"Exp Neurol"},{"key":"10.1016\/j.ajpath.2011.09.034_bib49","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1096\/fj.05-5632com","article-title":"BACE2, as a novel APP \u03b8-secretase, is not responsible for the pathogenesis of Alzheimer's disease in Down syndrome","volume":"20","author":"Sun","year":"2006","journal-title":"FASEB J"},{"key":"10.1016\/j.ajpath.2011.09.034_bib50","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.neurobiolaging.2006.06.023","article-title":"\u03b1- and \u03b2-secretase activity as a function of age and \u03b2-amyloid in Down syndrome and normal brain","volume":"28","author":"Nistor","year":"2007","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.ajpath.2011.09.034_bib51","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1073\/pnas.0908953107","article-title":"Alzheimer's-related endosome dysfunction in Down syndrome is A\u03b2-independent but requires APP and is reversed by BACE-1 inhibition","volume":"107","author":"Jiang","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2011.09.034_bib52","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0006-8993(01)03008-6","article-title":"Relationship between \u03b2 amyloid peptide generating molecules and neprilysin in Alzheimer disease and normal brain","volume":"919","author":"Yasojima","year":"2001","journal-title":"Brain Res"},{"key":"10.1016\/j.ajpath.2011.09.034_bib53","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.3233\/JAD-2010-101254","article-title":"BACE1 mRNA expression in Alzheimer's disease postmortem brain tissue","volume":"22","author":"Coulson","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.ajpath.2011.09.034_bib54","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.neurobiolaging.2004.10.005","article-title":"Age-dependent differential expression of BACE splice variants in brain regions of tg2576 mice","volume":"26","author":"Zohar","year":"2005","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.ajpath.2011.09.034_bib55","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1460-9568.2010.07482.x","article-title":"\u03b2-Secretase activity in rat astrocytes: translational block of BACE1 and modulation of BACE2 expression","volume":"33","author":"Bettegazzi","year":"2011","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.ajpath.2011.09.034_bib56","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/0361-9230(86)90074-2","article-title":"The neurobiologic consequences of Down syndrome","volume":"16","author":"Coyle","year":"1986","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.ajpath.2011.09.034_bib57","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.neuron.2008.02.024","article-title":"Transcriptional regulation of \u03b2-secretase by p25\/cdk5 leads to enhanced amyloidogenic processing","volume":"57","author":"Wen","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.ajpath.2011.09.034_bib58","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.neurobiolaging.2007.12.015","article-title":"JNK and ERK1\/2 pathways have a dual opposite effect on the expression of BACE1","volume":"30","author":"Tamagno","year":"2009","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.ajpath.2011.09.034_bib59","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/sj.embor.7400166","article-title":"Expression of the Alzheimer protease BACE1 is suppressed via its 5\u2032-untranslated region","volume":"5","author":"Lammich","year":"2004","journal-title":"EMBO Rep"},{"key":"10.1016\/j.ajpath.2011.09.034_bib60","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1523\/JNEUROSCI.5065-07.2008","article-title":"The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of \u03b2-site amyloid precursor protein-cleaving enzyme 1","volume":"28","author":"Wang","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.ajpath.2011.09.034_bib61","doi-asserted-by":"crossref","first-page":"6415","DOI":"10.1073\/pnas.0710263105","article-title":"Loss of microRNA cluster miR-29a\/b-1 in sporadic Alzheimer's disease correlates with increased BACE1\/\u03b2-secretase expression","volume":"105","author":"Hebert","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2011.09.034_bib62","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nm1784","article-title":"Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of \u03b2-secretase","volume":"14","author":"Faghihi","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.ajpath.2011.09.034_bib63","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1096\/fj.04-3426com","article-title":"Distinct transcriptional regulation and function of the human BACE2 and BACE1 genes","volume":"19","author":"Sun","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.ajpath.2011.09.034_bib64","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3233\/JAD-2009-1138","article-title":"Lifespan profiles of Alzheimer's disease-associated genes and products in monkeys and mice","volume":"18","author":"Dosunmu","year":"2009","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.ajpath.2011.09.034_bib65","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1002\/jnr.21695","article-title":"Transcription factor Sp1 dysregulation in Alzheimer's disease","volume":"86","author":"Citron","year":"2008","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.ajpath.2011.09.034_bib66","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1096\/fj.03-1378fje","article-title":"Gene structure and organization of the human \u03b2-secretase (BACE) promoter","volume":"18","author":"Sambamurti","year":"2004","journal-title":"FASEB J"},{"key":"10.1016\/j.ajpath.2011.09.034_bib67","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1385\/JMN:29:1:65","article-title":"Functional domains of the BACE1 and BACE2 promoters and mechanisms of transcriptional suppression of the BACE2 promoter in normal neuronal cells","volume":"29","author":"Lahiri","year":"2006","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.ajpath.2011.09.034_bib68","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00401-006-0077-5","article-title":"Characterization of A\u03b211\u201340\/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated A\u03b2 species in the pathogenesis of Alzheimer's disease","volume":"112","author":"Liu","year":"2006","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.ajpath.2011.09.034_bib69","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1126\/science.1197623","article-title":"Decreased clearance of CNS \u03b2-amyloid in Alzheimer's disease","volume":"330","author":"Mawuenyega","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2011.09.034_bib70","doi-asserted-by":"crossref","first-page":"17941","DOI":"10.1074\/jbc.M601372200","article-title":"Neprilysin-sensitive synapse-associated amyloid-\u03b2 peptide oligomers impair neuronal plasticity and cognitive function","volume":"281","author":"Huang","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2011.09.034_bib71","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.neurobiolaging.2004.06.013","article-title":"Age- and region-dependent alterations in A\u03b2-degrading enzymes: implications for A\u03b2-induced disorders","volume":"26","author":"Caccamo","year":"2005","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.ajpath.2011.09.034_bib72","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1097\/01.jnen.0000240463.87886.9a","article-title":"Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy","volume":"65","author":"Miners","year":"2006","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.ajpath.2011.09.034_bib73","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1471-4159.2010.06899.x","article-title":"Expression and functional profiling of neprilysin, insulin-degrading enzyme, and endothelin-converting enzyme in prospectively studied elderly and Alzheimer's brain","volume":"115","author":"Wang","year":"2010","journal-title":"J Neurochem"},{"key":"10.1016\/j.ajpath.2011.09.034_bib74","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/ana.20494","article-title":"Cerebrospinal fluid neprilysin is reduced in prodromal Alzheimer's disease","volume":"57","author":"Maruyama","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ajpath.2011.09.034_bib75","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/j.1750-3639.2010.00375.x","article-title":"Changes with age in the activities of \u03b2-secretase and the A\u03b2-degrading enzymes neprilysin, insulin-degrading enzyme and angiotensin-converting enzyme","volume":"20","author":"Miners","year":"2010","journal-title":"Brain Pathol"},{"key":"10.1016\/j.ajpath.2011.09.034_bib76","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3233\/JAD-2010-101395","article-title":"Accumulation of insoluble amyloid-\u03b2 in Down's syndrome is associated with increased BACE-1 and neprilysin activities","volume":"23","author":"Miners","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.ajpath.2011.09.034_bib77","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1007\/s00726-010-0662-8","article-title":"In vivo effects of APP are not exacerbated by BACE2 co-overexpression: behavioural characterization of a double transgenic mouse model","volume":"39","author":"Azkona","year":"2010","journal-title":"Amino Acids"},{"key":"10.1016\/j.ajpath.2011.09.034_bib78","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1083\/jcb.200407070","article-title":"BACE overexpression alters the subcellular processing of APP and inhibits A\u03b2 deposition in vivo","volume":"168","author":"Lee","year":"2005","journal-title":"J Cell Biol"},{"key":"10.1016\/j.ajpath.2011.09.034_bib79","doi-asserted-by":"crossref","first-page":"32957","DOI":"10.1074\/jbc.M507016200","article-title":"High \u03b2-secretase activity elicits neurodegeneration in transgenic mice despite reductions in amyloid-\u03b2 levels: implications for the treatment of Alzheimer disease","volume":"280","author":"Rockenstein","year":"2005","journal-title":"J Biol Chem"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944011009278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944011009278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T14:35:30Z","timestamp":1757601330000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944011009278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":79,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0002944011009278"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2011.09.034","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BACE2 Expression Increases in Human Neurodegenerative Disease","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2011.09.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}